Top Markets
Coin of the day
Pharmena S.a. Pharmena S.a.

Pharmena S.a.

PHR
Rang in Aktien #32515
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Aktienkurs
$0.88679187
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$9.88M
Veränderung (1 Tag)
-1.56%
Veränderung (1 Jahr)
-7.71%
Land
PL
Handel Pharmena S.a. (PHR)

Kategorie

Dividendenrendite-Verlauf für Pharmena S.a. (PHR)
Dividendenrendite (TTM) von Pharmena S.a. (Aktienkürzel: PHR) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Pharmena S.a. (PHR) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE